Semaglutide and tirzepatide are prescription medicines that can reduce appetite and support weight loss when used with nutrition, activity, and clinical follow-up. They act on different hormone pathways and cannot be chosen safely from social-media results alone. Medical history, current medicines, treatment goals, side effects, availability, and approved indications must guide the choice.
How the medicines differ
Semaglutide acts on the GLP-1 pathway. Tirzepatide acts on both GIP and GLP-1 pathways. Both can influence appetite, fullness, blood glucose, and digestion. They are administered according to a prescribed schedule, usually with gradual dose escalation when clinically appropriate.
A larger average result in a study does not predict what one person will achieve. Trial populations, doses, treatment duration, adherence, and health conditions differ. Patients should compare suitability and safety rather than selecting a medicine only by an advertised percentage.
Who may be assessed for treatment
A clinician may consider prescription weight-management medicine for an adult who meets applicable BMI and health criteria. The assessment may include diabetes, blood pressure, sleep apnea, liver health, digestive symptoms, previous gallbladder or pancreatic disease, pregnancy plans, and all current medicines.
Medication may form part of the clinic’s non-surgical weight-loss program. Some people may instead need a discussion about weight-loss injections versus bariatric surgery because the treatments differ in expected durability, burden, risk, and follow-up.
Common side effects and important warnings
Nausea, vomiting, diarrhoea, constipation, abdominal discomfort, and reduced appetite can occur. Starting low and increasing the dose only as prescribed may improve tolerability. Persistent vomiting can cause dehydration and requires medical advice.
Severe or persistent abdominal pain, inability to keep fluids down, symptoms of an allergic reaction, or other worrying changes need prompt assessment. These medicines are not suitable for everyone. Product warnings and contraindications differ, so a clinician must review personal and family history before prescribing.
Why the source of the medicine matters
Patients should use a legitimate prescription and an authorised pharmacy. Unapproved, counterfeit, or incorrectly compounded products may contain the wrong ingredient, concentration, or dosing instructions. The US Food and Drug Administration has specifically warned that unapproved GLP-1 products do not undergo its review for safety, effectiveness, and quality.
Never share an injection pen, copy another person’s dose, or buy a product solely because it is cheaper online. Availability and regulatory approval can differ by country and product, so patients in Pakistan should verify the exact medicine and manufacturer with their prescribing clinician and pharmacist.
What happens during follow-up
Follow-up should monitor weight, waist measurements where useful, nutrition, hydration, side effects, laboratory results when indicated, and changes in other medicines. People taking diabetes or blood-pressure treatment may need closer monitoring as weight and food intake change.
Treatment also needs a maintenance plan. Stopping medicine may be followed by increased appetite or weight regain in some patients. Discuss the likely duration, affordability, and next steps before beginning.
How to decide
The safest choice is an individual treatment plan. Ask about approved use, expected benefit, side effects, dose escalation, monitoring, cost over time, and alternatives. Patients can review non-surgical options, learn about bariatric solutions, or contact the clinic for assessment.
Frequently asked questions
Which medicine causes more weight loss
Average trial results may differ, but individual response and tolerability vary. A clinician should interpret the evidence for your circumstances.
Can I use these injections without diabetes
Some formulations may be indicated for chronic weight management in people without diabetes, subject to local approval and clinical criteria.
Can I take them during pregnancy
Weight-loss medicines are generally not used during pregnancy. Discuss pregnancy plans with the prescriber before treatment.
Do injections replace diet and activity
No. They work best within a structured plan that protects nutrition, muscle, activity, and long-term habits.
Treatment should be based on an individual medical assessment. Contact Doctor Obesity Clinic to discuss your health, treatment options, and next steps.